Clin Case Rep . Giant cell myocarditis following COVID-19 successfully treated by immunosuppressive therapy

[tetano]

Clin Case Rep


. 2022 Aug 9;10(8):e6196.
doi: 10.1002/ccr3.6196. eCollection 2022 Aug.
Giant cell myocarditis following COVID-19 successfully treated by immunosuppressive therapy


Afsaneh Amiri ¹ , Golnaz Houshmand ¹ , Sepideh Taghavi ¹ , Monireh Kamali ¹ , Mona Faraji ¹ , Nasim Naderi ¹



Affiliations

• PMID: 35957785
• PMCID: PMC9361461
• DOI: 10.1002/ccr3.6196

Abstract

It has been shown that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), by coronavirus disease 2019 (COVID-19), can lead to multi-organ impairment including cardiac involvement and immunological problems. Acute myocarditis is one of serious and fatal complications of COVID-19. In this case report, we present a 46-year-old lady with a history of lichen planus dermatitis who has developed a rapidly progressive heart failure after an episode of COVID-19. The pathologic examination of her endomyocardial biopsy specimens was compatible with GCM, and she was successfully treated with a combined immunosuppressive therapy regimen.

Keywords: COVID‐19; Giant cell; myocarditis.